Taulí Research and Innovation Grants
TAI-certified Taulí Grants aims to promote research and innovation among I3PT research professionals, helping to fund projects of excellence and also helping emerging groups to develop their projects and gain enough experience to be competitive in competitive calls.
Taulí Scholarships are announced annually and incorporate three modalities:
- Aid for the search of accredited groups of the I3PT.
- Grants for innovation projects.
- Research incentives for medical students at the UAB.
The Taulí Scholarships will be awarded at the end of the year in one of the most important institutional events at Parc Taulí, where they participate. prestigious speakers of the world of research with lectures:
Currently, an average of 75 projects are presented each year, of which 25% are awarded. All projects are evaluated by a Committee of Evaluators in which more than 70 professionals participate.
Evolution of the financial endowment of the Taulí Scholarships (in thousands of €)
Step up on the Taulí
The internal intensification program was born in 2016, has an annual frequency and has the collaboration of the Banco Sabadell Foundation.
The program Step up aims to encourage the research and innovation activity of research groups through the allocation of partial or total dedication exclusively to research, with solid objectives and the commitment of researchers who submit their applications.
The intensification of healthcare staff allows researchers to better combine their care work with research and facilitates the translation of results into clinical practice improvements with the aim of maintaining quality healthcare.
How have our researchers taken advantage of the intensification?
Joan Calvet | INTENSIFIED IN THE 2020 CALL
The intensification has allowed me to move forward with “Taby Diagnostics,” a project that will improve the early diagnosis of liver cancer through technology that increases the immunogenicity of tumor-associated antigens. Specifically, I was able to perform a series of experiments with which I obtained a solid proof of concept, thanks to the fact that I had added an extra control group of patients (chronic active liver diseases) and the possibility of making a patent for the epitope. identified immunodominant, which will facilitate the creation of a spin-off to commercialize the technology.
The intensification program is a clear success. It has allowed me to consolidate the area of vascular access by hemodialysis, not only at the teaching level, but also in terms of research and innovation, opening lines of collaboration at the national and international level. On the other hand, it has allowed me to develop the area of computational simulation and artificial intelligence in nephrology. All this has generated 11 publications, participation in 5 proposals for European projects (leading one of them for the next call H2020), the application for the first patent within the ANAIS project, the transfer of Nephrocloud software to the market, the generation of a Master in Artificial Intelligence in Health, a translational research agreement with the University of North Carolina and the coordination of a national multicenter and 2 projects in vascular biology and hemodynamics.
I carried out the FIS project (PI14 / 02057) on the study of alternative brain pathways to hunger and satiety in patients with Prader-Willi syndrome (SPW), specifically the pathways of disgust. These pathways were altered and open the possibility of new therapeutic targets. I was also able to do a stay at Columbia University’s New York Obesity Center to study the effect of bariatric surgery on microbiota metabolomics. All in all, it allowed the “Obesity and SPW” research group to grow, obtaining first-quartile publications and encouraging their projection both nationally and internationally.
The intensification has allowed me to have half a day of my working hours to devote myself fully to research. During this time, I have strengthened the research groups I coordinate and the lines of chronic obstructive pulmonary disease, respiratory microbiome, and lung cancer, in which I work personally. All this activity has facilitated the execution of 16 projects and the publication of 12 scientific articles exposing the results obtained. Among these results, we were able to identify prognostic markers of lung cancer in its early stages, which could reduce its mortality. We have also been able to better identify the causes of COPD exacerbation episodes.
Awards for the Improvement of Care Quality
The Awards for the Improvement of Care Quality they seek to recognize, empowering and emerging, the initiatives to improve professionals, in any of the dimensions of quality, that are being carried out, or are considered to be done, in the institution.
Care needs are constantly changing and professionals strive to adapt our work to these demands. We do this, usually, seeking the incorporation of new diagnostic and therapeutic technologies, or more effective and safer drugs. But also, very important, adapting its use (avoiding overuse) and with new ways of doing work and organizing ourselves (process improvement), for the benefit of our patients. This benefit can translate into advancing patient-centered care (better emotional support and shared decision making), greater effectiveness, better response over time, more security, efficiency, and / or equity.
The first call for Quality Awards took place in 2017. Every year, three awards are given to the best rated projects, by the Hospital Quality Committee, of the total number of projects submitted, which is around 50 annual proposals.